Tomoka Hisada, Naoto Kondo, Yumi Wanifuchi-Endo, Satoshi Osaga, Takashi Fujita, Tomoko Asano, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, et al. Co-expression effect of LLGL2 and SLC7A5 to predict prognosis in ERα-positive breast cancer. Scientific reports. 2022. 12. 1. 16515-16515
Mitsuo Terada, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Akiko Kato, Natsumi Yamanaka, Hiroshi Sugiura, et al. Efficacy and impact of SARS-CoV-2 vaccination on cancer treatment for breast cancer patients: a multi-center prospective observational study. Breast cancer research and treatment. 2022. 195. 3. 311-323
Yumi Wanifuchi-Endo, Naoto Kondo, Yu Dong, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Yasuaki Uemoto, Sayaka Nishikawa, Yusuke Katagiri, Akiko Kato, et al. Discovering novel mechanisms of taxane resistance in human breast cancer by whole-exome sequencing. Oncology letters. 2022. 23. 2. 60-60
Yasuaki Uemoto, Eriko Katsuta, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Mitsuo Terada, Akiko Kato, Katsuhiro Okuda, et al. Low HECTD1 mRNA expression is associated with poor prognosis and may be correlated with increased mitochondrial respiratory function in breast cancer. American journal of cancer research. 2022. 12. 4. 1593-1605
Yasuaki Uemoto, Megumi Uchida, Naoto Kondo, Yumi Wanifuchi-Endo, Takashi Fujita, Tomoko Asano, Tomoka Hisada, Sayaka Nishikawa, Yusuke Katagiri, Mitsuo Terada, et al. Predictive factors for patients who need treatment for chronic post-surgical pain (CPSP) after breast cancer surgery. Breast cancer (Tokyo, Japan). 2021. 28. 6. 1346-1357